Dr Radha Krishnan is the Executive director and clinical pathology lead, at Merck Sharpe and Dohme, London, UK. Dr. Krishnan specialises in surgical pathology specifically in the neoadjuvant/adjuvant space, immune-oncology, specifically PD-L1, biomarker assay validations. Within the context of the changing healthcare landscape at the intersection of data sciences and technology, Dr Krishnan is actively involved in efforts to leverage informatics, machine learning and AI methodologies in precision medicine across therapeutic areas of oncology and NASH. For more than a decade before transitioning to industry, Dr Krishnan was the Chief Pathologist at one of the largest Clinical research organisations supporting clinical trials where she was leading anatomic pathology services, biomarker assay development and companion diagnostics.